News

Michiel Voskuil, MD, PhD, an interventional cardiologist and professor at University Medical Center Utrecht in the Netherlands, presented his team’s data on the ACC.26 stage.

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.

Whoop, a Boston-based wearable technologies company, has raised $575 million in new financing at a $10.1 billion valuation. Investors include Abbott, Mayo Clinic, LeBron James and Cristiano Ronaldo.

Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.

Interventional cardiologist Roxana Mehran, MD, officially started her one-year term as the president of the American College of Cardiology (ACC) on the closing day of ACC.26, the group’s annual conference in New Orleans.

A prominent figure in the fields of interventional cardiology and women’s health is now leading the American College of Cardiology.

radiology clock alarm turnaround time efficiency

“These increases likely indicate that the radiology workforce has reached maximum capacity," Neiman Health Policy Institute experts write in JACR. 

Man vs. Machine artificial intelligence AI

Mitchell H. Katz, MD, president and CEO of NYC Health + Hospitals, recently spoke during a panel discussion held by Crain’s New York Business. 

Department of Justice DOJ

Authorities claim NewYork-Presbyterian wielded plan restrictions to stop one insurer from steering beneficiaries to other imaging options. 

St. Anthony's Hospital BayCare

About $10 million of the total will cover construction, with BayCare adding two new bi-plane suites at St. Anthony's Hospital in St. Petersburg, Florida.

Happy doctor physician

Three-fifths of 14,000 physicians surveyed, 60%, enjoy a strong sense of belonging within their organization. Better yet, four-fifths, 80%, feel their teammates have their back.

Semaglutide, the GLP-1 receptor agonist sold by Novo Nordisk under the brand names Wegovy and Ozempic, is associated with significant health benefits for patients with type 2 diabetes and peripheral artery disease (PAD), according to a late-breaking clinical trial presented at ACC.25, the annual meeting of the American College of Cardiology (ACC).

Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.

Thumbnail

In an open letter, advocacy groups said the budget proposal passed by the U.S. House of Representatives would “shred our nation’s social safety net.”

Interval breast cancer rates on the rise.

A new analysis suggests interval cancer rates among women with a prior history of breast cancer may be as high as 30%.

GE HealthCare Revolution Vibe CCTA

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Around the web

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.